Kathrin Ohla

Dr. Kathrin Ohla

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2014 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
JBJens Blechert
Jens Blechert
AMAdrian Meule
Adrian Meule
NBNiko A. Busch
Niko A. Busch
KOKathrin Ohla
Kathrin Ohla
Our current environment is characterized by the omnipresence of food cues. The sight and smell of real foods, but also graphically depictions of appetizing foods, can guide our eating behavior, for example, by eliciting food craving and influencing food choice. The relevance of visual food cues on human information processing has been demonstrated by a growing body of studies employing food images across the disciplines of psychology, medicine, and neuroscience. However, currently used food image sets vary considerably across laboratories and image characteristics (contrast, brightness, etc.) and food composition (calories, macronutrients, etc.) are often unspecified. These factors might have contributed to some of the inconsistencies of this research. To remedy this, we developed food-pics, a picture database comprising 568 food images and 315 non-food images along with detailed meta-data. A total of N = 1988 individuals with large variance in age and weight from German speaking countries and North America provided normative ratings of valence, arousal, palatability, desire to eat, recognizability and visual complexity. Furthermore, data on macronutrients (g), energy density (kcal), and physical image characteristics (color composition, contrast, brightness, size, complexity) are provided. The food-pics image data base is freely available under the creative commons license with the hope that the set will facilitate standardization and comparability across studies and advance experimental research on the determinants of eating behavior.

20 June 2020 in Chemical Senses
Verified
Journal Article
Open access
PDF file
VPValentina Parma
Valentina Parma
KOKathrin Ohla
Kathrin Ohla
MVMaria G Veldhuizen
Maria G Veldhuizen
MNMasha Y Niv
Masha Y Niv
CKChristine E Kelly
Christine E Kelly
JHJohn Hayes
John Hayes
Recent anecdotal and scientific reports have provided evidence of a link between COVID-19 and chemosensory impairments, such as anosmia. However, these reports have downplayed or failed to distinguish potential effects on taste, ignored chemesthesis, and generally lacked quantitative measurements. Here, we report the development, implementation, and initial results of a multilingual, international questionnaire to assess self-reported quantity and quality of perception in 3 distinct chemosensory modalities (smell, taste, and chemesthesis) before and during COVID-19. In the first 11 days after questionnaire launch, 4039 participants (2913 women, 1118 men, and 8 others, aged 19–79) reported a COVID-19 diagnosis either via laboratory tests or clinical assessment. Importantly, smell, taste, and chemesthetic function were each significantly reduced compared to their status before the disease. Difference scores (maximum possible change ±100) revealed a mean reduction of smell (−79.7 ± 28.7, mean ± standard deviation), taste (−69.0 ± 32.6), and chemesthetic (−37.3 ± 36.2) function during COVID-19. Qualitative changes in olfactory ability (parosmia and phantosmia) were relatively rare and correlated with smell loss. Importantly, perceived nasal obstruction did not account for smell loss. Furthermore, chemosensory impairments were similar between participants in the laboratory test and clinical assessment groups. These results show that COVID-19-associated chemosensory impairment is not limited to smell but also affects taste and chemesthesis. The multimodal impact of COVID-19 and the lack of perceived nasal obstruction suggest that severe acute respiratory syndrome coronavirus strain 2 (SARS-CoV-2) infection may disrupt sensory-neural mechanisms.

25 December 2020 in Chemical Senses
Verified
Journal Article
Open access
PDF file
RGRichard C Gerkin
Richard C Gerkin
KOKathrin Ohla
Kathrin Ohla
MVMaria G Veldhuizen
Maria G Veldhuizen
Paule Valery JosephPaule Valery Joseph
Paule Valery Joseph
CKChristine E Kelly
Christine E Kelly
MBMarius Baguma
Marius Baguma
In a preregistered, cross-sectional study, we investigated whether olfactory loss is a reliable predictor of COVID-19 using a crowdsourced questionnaire in 23 languages to assess symptoms in individuals self-reporting recent respiratory illness. We quantified changes in chemosensory abilities during the course of the respiratory illness using 0–100 visual analog scales (VAS) for participants reporting a positive (C19+; n = 4148) or negative (C19−; n = 546) COVID-19 laboratory test outcome. Logistic regression models identified univariate and multivariate predictors of COVID-19 status and post-COVID-19 olfactory recovery. Both C19+ and C19− groups exhibited smell loss, but it was significantly larger in C19+ participants (mean ± SD, C19+: −82.5 ± 27.2 points; C19−: −59.8 ± 37.7). Smell loss during illness was the best predictor of COVID-19 in both univariate and multivariate models (ROC AUC = 0.72). Additional variables provide negligible model improvement. VAS ratings of smell loss were more predictive than binary chemosensory yes/no-questions or other cardinal symptoms (e.g., fever). Olfactory recovery within 40 days of respiratory symptom onset was reported for ~50% of participants and was best predicted by time since respiratory symptom onset. We find that quantified smell loss is the best predictor of COVID-19 amongst those with symptoms of respiratory illness. To aid clinicians and contact tracers in identifying individuals with a high likelihood of having COVID-19, we propose a novel 0–10 scale to screen for recent olfactory loss, the ODoR-19. We find that numeric ratings ≤2 indicate high odds of symptomatic COVID-19 (4 < OR < 10). Once independently validated, this tool could be deployed when viral lab tests are impractical or unavailable.

1 January 2013 in Neuropharmacology
Verified
Journal Article
Closed access
MDMartin Dresler
Martin Dresler
ASAnders Sandberg
Anders Sandberg
KOKathrin Ohla
Kathrin Ohla
CBChristoph Bublitz
Christoph Bublitz
CTCarlos Trenado
Carlos Trenado
DRDimitris Repantis
Dimitris Repantis

14 December 2018 in ACS Chemical Neuroscience
Verified
Journal Article
Open access
MDMartin Dresler
Martin Dresler
ASAnders Sandberg
Anders Sandberg
CBChristoph Bublitz
Christoph Bublitz
KOKathrin Ohla
Kathrin Ohla
CTCarlos Trenado
Carlos Trenado
DRDimitris Repantis
Dimitris Repantis
In an increasingly complex information society, demands for cognitive functioning are growing steadily. In recent years, numerous strategies to augment brain function have been proposed. Evidence for their efficacy (or lack thereof) and side effects has prompted discussions about ethical, societal and medical implications. In the public debate, cognitive enhancement is often seen as a monolithic phenomenon. On a closer look, however, cognitive enhancement turns out to be a multifaceted concept: There is not one cognitive enhancer that augments brain function per se, but a great variety of interventions that can be clustered into biochemical, physical and behavioral enhancement strategies. These cognitive enhancers differ in their mode of action, the cognitive domain they target, the timescale they work on, their availability and side effects, and how they differentially affect different groups of subjects. Here we disentangle the dimensions of cognitive enhancement, review prominent examples of cognitive enhancers that differ across these dimensions, and thereby provide a framework for both theoretical discussions and empirical research.

1 April 2017 in Appetite
Verified
Journal Article
Closed access
SHSamyogita Hardikar
Samyogita Hardikar
RHRichard Höchenberger
Richard Höchenberger
AVArno Villringer
Arno Villringer
KOKathrin Ohla
Kathrin Ohla